Stockwinners Market Radar for September 26, 2021 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
GOOG... | Hot Stocks20:07 EDT Fly Intel: Top five weekend stock stories - Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Google (GOOG) is reducing the amount of revenue it keeps when customers buy software from other vendors on its cloud marketplace, as the top tech companies face increasing pressure to lower their so-called take rates, CNBC's Jordan Novet reported. The Google Cloud Platform is cutting its percentage revenue share to 3% from 20%, according to a person familiar with the matter who asked not be named in order to talk about internal policies. 2. Polestar is nearing a deal to go public through a merger with a special-purpose acquisition company that would value the Swedish electric-vehicle maker at $21 billion, The Wall Street Journal's Cara Lombardo reported, citing people familiar with the matter. Polestar, owned by Chinese car maker Zhejiang Geely, is in advanced talks with Gores Guggenheim (GGPI) and could reach a deal by Monday, the people said. Polestar focuses on high-performance electric cars, positioning itself as a rival to Tesla (TSLA) and Lucid (LCID). Zhejiang Geely is controlled by its billionaire chairman and founder Li Shufu. It owns Geely Automobile (GELYF), Volvo Car Group and several other electric-vehicle brands, the author noted. 3. In television, the dongle is dead, and set makers are suddenly gaining show-business swagger. Stock buyers should consider newly public Vizio, which completed "upfront" advertising negotiations with more than $100 million in commitments, up fourfold from last year, Jack Hough wrote in this week's edition of Barron's. Cheap, small devices like the Amazon Fire Stick (AMZN) or Google Chromecast, along with Apple TV (AAPL) set-top boxes, gave old sets sleek operating systems and provided access to Netflix (NFLX) and more, but that's changing, the author notes. Only 7% of time spent watching a Vizio (VZIO) set isn't spent on Vizio's own operating system. Dongles are out, in other words, the publication says. 4. Disney's (DIS) "Shang-Chi and the Legend of the Ten Rings" remained atop the box office charts in its fourth weekend, earning another $13.3M as it became the top-grossing pic of the pandemic era in North America. The movie finished Sunday with a domestic gross of $196.5M and $166.9M overseas for a global total of $363.4M. "Shang-Chi" sports an A Cinemascore and unlike fellow Marvel Studios pic "Black Widow," it has an exclusive 45-day theatrical release. 5. Scotts Miracle-Gro (SMG), Li-Cycle (LICY), and Volkswagen (VWAGY) saw positive mentions in this week's edition of Barron's.
|
APO | Hot Stocks14:21 EDT Closing of acquisition by Apollo Funds of approximately 67% stake in RDM group - Apollo Global Management announced that the closing of the acquisition of a majority stake in Reno De Medici S.p.A., which is subject to customary closing conditions, is expected to take place by Q4 2021. As announced on July 5, 2021, certain funds managed by Apollo's affiliates have entered into definitive agreements to acquire approx. 67% equity ownership in RDM from the company's top two shareholders, Cascades and Caisse de depot et placement du Quebec, for EUR 1.45 per share. Upon closing, the Apollo Funds will launch a mandatory public tender offer on all the remaining RDM shares - including all the ordinary shares deriving from the conversion of the convertible savings shares of the Company, to the extent such shares are converted prior to the expiration of the mandatory public tender offer -, with the aim to de-list the Company.
|
LLY | Hot Stocks08:51 EDT Eli Lilly issues voluntary recall of lot of Glucagon Emergency Kit for Low Blood - Eli Lilly is voluntarily recalling lot D239382D, Expiration April 2022, of Glucagon Emergency Kit for Low Blood Sugar to the consumer/user level. Lilly is recalling lot D239382D to the patient level because of a product complaint reporting that the vial of Glucagon was in liquid form instead of the powder form. The company's investigation indicates that the liquid in this Glucagon vial could be related to the manufacturing process. The use of the liquid form of this product may fail to treat severe low blood sugar due to loss of potency. Risk Statement: Severe hypoglycemia in patients with diabetes, if not reversed, can potentially cause adverse health consequences ranging from transient, minor complaints to neurological damage, seizures, and even death if not promptly treated. Associated with the one product complaint, it was reported to Lilly that the involved patient experienced lack of drug effect and also reported subsequent seizures. Lilly is notifying its distributors and customers by written communication and is arranging for return and replacement of all recalled products. Wholesalers and Distributors with an existing inventory of Glucagon Emergency Kit lot D239382D should cease distribution and quarantine the product immediately.
|